🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06886711
Starting soon Not applicable

Research on the Role of Probiotics in Human Intestinal Health

NCT06886711 · tracked via the Priya Life Science China tracker
Sponsor
Wecare Probiotics Co., Ltd.
Phase
Not applicable
Started
2025-03-10
Last updated
2025-03-20

Condition(s) studied

Intestinal Microbiota

Investigational drug(s) / intervention(s)

ProbioticPlacebo

Probiotic: Dietary supplement: Probiotics. The trial period of this study lasts for 2 months(8weeks), during which each participant will have 3 visits (at month 0, month 1, andmonth 2).

Placebo: Dietary supplement: Placebo. The trial period of this study lasts for 2 months(8weeks), during which each participant will have 3 visits (at month 0, month 1, andmonth 2).

Study summary

Evaluate the efectiveness and safety of Bifidobacterium bifidum BBi32 as a food supplement compared to a placebo in improving intestinal andimmune functions in healthy adults.

Eligibility

Sex
ALL
Min age
18 Years
Max age
45 Years
Healthy volunteers
Accepted
Inclusion Criteria: 1. Willing to attend 3 follow-up visits during the intervention period 2. Agree to provide blood, urine, and stool samples twice during the intervention period 3. Good eyesight, able to read and write, and capable of wearing glasses if needed 4. Good hearing and able to fully comprehend all instructions during the intervention Exclusion Criteria: 1. Presence of digestive diseases, particularly gastrointestinal disorders (e.g., celiac disease, ulcerative colitis, Crohn's disease) 2. History of serious neurological conditions (e.g., epilepsy, stroke, severe head trauma, meningitis within the last 10 years, brain surgery, brain tumor, or prolonged coma-not including general anesthesia) 3. History of or currently receiving treatment for mental health disorders such as alcohol/drug/substance abuse, schizophrenia, psychosis, or bipolar disorder 4. Currently taking medication for depression or low mood 5. Presence of internal organ failure (e.g., heart, liver, or kidney failure) 6. History of radiation therapy or chemotherapy treatments 7. Underwent general anesthesia within the past three years or are scheduled for general anesthesia within the next 3 months during the trial period 8. History of hepatitis (B or C), HIV, or syphilis

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Henan University of Technology Zhengzhou Henan

More Wecare Probiotics Co., Ltd. trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06886711 on ClinicalTrials.gov ↗ ← All trials in China